Radiation to the Normal Lung May be an Important Risk Factor for Survival after Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer

• DOI: 10.1016/j.ijrobp.2017.06.1726
• Publication Date: 2017-09-23T03:33:57Z
• Authors: F.M. Kong; Y. LIU; A. Cerra-Franco; K. Shiue; D. Vile; H. Yao; W. Wang; M.P. Langer; G. Watson; G. Bartlett; K. Diab; T. Birdas; R.D. Timmerman; T. Lautenschlaeger; J.Y. Jin
• Keywords: Clinical endpoint